Literature DB >> 25416862

Up-regulation of UHRF1 by oncogenic Ras promoted the growth, migration, and metastasis of pancreatic cancer cells.

Lei Cui1, Jixiang Chen, Qing Zhang, Xuqing Wang, Jianguo Qu, Jianxin Zhang, Shenchun Dang.   

Abstract

Ubiquitin-like with PHD and ring finger domains 1 (UHRF1) has been reported as a marker for the differential diagnosis of pancreatic cancer and chronic pancreatitis. However, the expression pattern and biological functions of UHRF1 in the progression of pancreatic cancer are not fully understood. In this study, it was found that the expression of UHRF1 was significantly up-regulated in pancreatic cancer samples compared to their adjacent normal tissues. Meanwhile, the expression of UHRF1 was inversely correlated with the survival of pancreatic cancer patients. Moreover, in the biological function studies, UHRF1 was shown to promote the growth, migration, and metastasis of pancreatic cancer cells in vitro and in vivo. Mechanistically, the expression of UHRF1 was induced by oncogenic Ras in both pancreatic cancer mouse model and cultured cells. Taken together, our study demonstrated that UHRF1 played an oncogenic role in the progression of pancreatic cancer, and UHRF1 might be a promising target for the treatment of pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25416862     DOI: 10.1007/s11010-014-2279-9

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  32 in total

1.  UHRF1: a master regulator in prostate cancer.

Authors:  Ali R Jazirehi; Dylan Arle; Peter B Wenn
Journal:  Epigenomics       Date:  2012-06       Impact factor: 4.778

2.  Inhibiting K-ras signaling reserves the epithelial-mesenchymal transition of pancreatic cancer cells and its mechanisms.

Authors:  Xing-E Liu; Xiao-Do Sun
Journal:  Hepatogastroenterology       Date:  2013 Jul-Aug

3.  TCR pathway involves ICBP90 gene down-regulation via E2F binding sites.

Authors:  Abdul-Qader Abbady; Christian Bronner; Kawtar Bathami; Christian D Muller; Michaël Jeanblanc; Eric Mathieu; Jean Paul Klein; Ermanno Candolfi; Marc Mousli
Journal:  Biochem Pharmacol       Date:  2005-08-15       Impact factor: 5.858

4.  Activated K-Ras and INK4a/Arf deficiency promote aggressiveness of pancreatic cancer by induction of EMT consistent with cancer stem cell phenotype.

Authors:  Zhiwei Wang; Shadan Ali; Sanjeev Banerjee; Bin Bao; Yiwei Li; Asfar S Azmi; Murray Korc; Fazlul H Sarkar
Journal:  J Cell Physiol       Date:  2013-03       Impact factor: 6.384

5.  Down-regulation of cyclic nucleotide phosphodiesterase PDE1A is the key event of p73 and UHRF1 deregulation in thymoquinone-induced acute lymphoblastic leukemia cell apoptosis.

Authors:  Abdurazzag Abusnina; Mahmoud Alhosin; Thérèse Keravis; Christian D Muller; Guy Fuhrmann; Christian Bronner; Claire Lugnier
Journal:  Cell Signal       Date:  2010-08-31       Impact factor: 4.315

6.  UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.

Authors:  Wei Jin; Li Chen; Ying Chen; Si-Guang Xu; Gen-Hong Di; Wen-Jin Yin; Jiong Wu; Zhi-Ming Shao
Journal:  Breast Cancer Res Treat       Date:  2009-11-27       Impact factor: 4.872

7.  Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism.

Authors:  Kyohei Arita; Mariko Ariyoshi; Hidehito Tochio; Yusuke Nakamura; Masahiro Shirakawa
Journal:  Nature       Date:  2008-09-03       Impact factor: 49.962

Review 8.  Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation.

Authors:  Tsutomu Chiba; Hiroyuki Marusawa; Toshikazu Ushijima
Journal:  Gastroenterology       Date:  2012-07-13       Impact factor: 22.682

9.  The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression.

Authors:  M Achour; X Jacq; P Rondé; M Alhosin; C Charlot; T Chataigneau; M Jeanblanc; M Macaluso; A Giordano; A D Hughes; V B Schini-Kerth; C Bronner
Journal:  Oncogene       Date:  2007-10-15       Impact factor: 9.867

10.  Reverse-phase protein array analysis to identify biomarker proteins in human pancreatic cancer.

Authors:  Yu-Jing Huang; Marsha L Frazier; Nianxiang Zhang; Qian Liu; Chongjuan Wei
Journal:  Dig Dis Sci       Date:  2013-11-19       Impact factor: 3.199

View more
  17 in total

Review 1.  Zebrafish Discoveries in Cancer Epigenetics.

Authors:  Yelena Chernyavskaya; Brandon Kent; Kirsten C Sadler
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

2.  Proteomic identification of nuclear processes manipulated by cytomegalovirus early during infection.

Authors:  Dominique M Carter; Kristen Westdorp; Kathleen R Noon; Scott S Terhune
Journal:  Proteomics       Date:  2015-04-28       Impact factor: 3.984

3.  Elevated expression of UHRF1 predicts unfavorable prognosis for patients with hepatocellular carcinoma.

Authors:  Dong Liang; Huanzhou Xue; Yang Yu; Feng Lv; Wei You; Bin Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

4.  A pooled genome-wide association study identifies pancreatic cancer susceptibility loci on chromosome 19p12 and 19p13.3 in the full-Jewish population.

Authors:  Samantha A Streicher; Alison P Klein; Sara H Olson; Robert C Kurtz; Laufey T Amundadottir; Andrew T DeWan; Hongyu Zhao; Harvey A Risch
Journal:  Hum Genet       Date:  2020-07-15       Impact factor: 4.132

5.  Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p.

Authors:  Zofia Wotschofsky; Linda Gummlich; Julia Liep; Carsten Stephan; Ergin Kilic; Klaus Jung; Jean-Noel Billaud; Hellmuth-Alexander Meyer
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

6.  Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy.

Authors:  Hani Choudhry; Mazin A Zamzami; Ziad Omran; Wei Wu; Marc Mousli; Christian Bronner; Mahmoud Alhosin
Journal:  Oncol Lett       Date:  2017-10-30       Impact factor: 2.967

7.  Transcriptional landscape of human cancers.

Authors:  Mengyuan Li; Qingrong Sun; Xiaosheng Wang
Journal:  Oncotarget       Date:  2017-05-23

8.  Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma.

Authors:  Xincheng Liu; Huohui Ou; Leyang Xiang; Xianghong Li; Yu Huang; Dinghua Yang
Journal:  Oncotarget       Date:  2017-02-07

9.  UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis.

Authors:  Wafa Abu-Alainin; Thompson Gana; Triantafillos Liloglou; Adedamola Olayanju; Lawrence N Barrera; Robert Ferguson; Fiona Campbell; Timothy Andrews; Christopher Goldring; Neil Kitteringham; Brian K Park; Taoufik Nedjadi; Michael C Schmid; Joseph R Slupsky; William Greenhalf; John P Neoptolemos; Eithne Costello
Journal:  J Pathol       Date:  2015-11-30       Impact factor: 7.996

Review 10.  The epigenetic integrator UHRF1: on the road to become a universal biomarker for cancer.

Authors:  Christian Bronner; Marc Mousli; Waseem Ashraf; Abdulkhaleg Ibrahim; Mahmoud Alhosin; Liliyana Zaayter; Khalid Ouararhni; Christophe Papin; Tanveer Ahmad; Ali Hamiche; Yves Mély
Journal:  Oncotarget       Date:  2017-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.